Medaphor Group PLC Payment of deferred consideration (6265N)
August 10 2017 - 2:37AM
UK Regulatory
TIDMMED
RNS Number : 6265N
Medaphor Group PLC
10 August 2017
10 August 2017
MedaPhor Group plc
("MedaPhor" the "Company")
Payment of deferred consideration
On 3 August 2016, MedaPhor Group plc (AIM: MED), the global
provider of advanced ultrasound skills training simulators for
medical professionals, announced the acquisition of Inventive
Medical Limited ("IML"). Further to the terms of the acquisition,
2,325,582 new ordinary shares are being issued to The Incorporated
Trustees of University College London Hospitals Charities (the
"Retention Shares"). The issue of the Retention Shares was
contingent on no seller warranty or indemnity breaches (as
specified in the IML Sale and Purchase Agreement) arising during
the 12 month period following the acquisition. The directors can
confirm no seller warranty or indemnity breaches have occurred.
Application has been made for admission of the Retention Shares
to be admitted to trading on the AIM market of the London Stock
Exchange ("Admission") and it is expected that Admission will
become effective on 16 August 2017. Following Admission the total
number of voting rights of the Company's Ordinary Shares will be
34,224,158.
Enquiries:
MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Cenkos Securities Tel: +44 (0)20 7397 8900
Bobbie Hilliam (Nominated
Adviser)
Walbrook PR Tel: +44 (0)20 7933 8780
or medaphor@walbrookpr.com
Paul McManus / Anna Mob: +44 (0)7980 541 893
Dunphy / Mob: +44 (0)7876 741 001
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUROBRBUAWARR
(END) Dow Jones Newswires
August 10, 2017 03:37 ET (07:37 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024
